{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:13:30Z","timestamp":1775045610267,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cllc.2025.12.003","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:44:15Z","timestamp":1765212255000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung SBRT Outcomes for Inoperable Early-Stage Lung Cancer Are Impaired in Patients With Solid Organ Transplants"],"prefix":"10.1016","volume":"27","author":[{"given":"Gregory M.M.","family":"Videtic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana A.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Stephans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2025.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2025.12.003_bib0002","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cncr.31782","article-title":"Survival after a cancer diagnosis among solid organ transplant recipients in the United States","volume":"125","author":"D'Arcy","year":"2019","journal-title":"Cancer"},{"issue":"a015677","key":"10.1016\/j.cllc.2025.12.003_bib0003","first-page":"1","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cllc.2025.12.003_bib0004","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2025.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/JTO.0b013e31818e1259","article-title":"Bronchogenic carcinoma after lung transplantation: characteristics and outcomes","volume":"3","author":"Minai","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0006","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archsurg.139.8.902","article-title":"Lung cancer in transplant recipients: a single-institution experience","volume":"139","author":"Ahmed","year":"2004","journal-title":"Arch Surg"},{"key":"10.1016\/j.cllc.2025.12.003_bib0007","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.athoracsur.2014.04.014","article-title":"Primary lung cancer in lung transplant recipients","volume":"98","author":"Olland","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2025.12.003_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.lungcan.2020.06.018","article-title":"Characteristics and outcomes of lung cancer in solid organ transplant recipients","volume":"146","author":"Chen","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2025.12.003_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2017.10.037","article-title":"Tumor control and toxicity for common stereotactic body radiation therapy dose-fractionation regimens in stage I non-small cell lung cancer","volume":"100","author":"Stephans","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.12.003_bib0011","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0012","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.12.003_bib0013","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2020.01.018","article-title":"To biopsy or not to biopsy?: A matched cohort analysis of early-stage lung cancer treated with stereotactic radiation with or without histologic confirmation","volume":"107","author":"Dautruche","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.12.003_bib0015","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.prro.2017.06.011","article-title":"Never too old: a single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0016","unstructured":"Institute NC. Common terminology criteria for adverse events v3.0 (CTCAE). 2006. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v3.pdf; Accessed Date 6 oct, 2025."},{"key":"10.1016\/j.cllc.2025.12.003_bib0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/OP.22.00475","article-title":"Stereotactic body radiotherapy for the management of early-stage non-small-cell lung cancer: a clinical overview","volume":"19","author":"Buchberger","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.cllc.2025.12.003_bib0018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2478\/raon-2020-0022","article-title":"Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant","volume":"54","author":"Moore","year":"2020","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00066-013-0511-2","article-title":"Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy. A case study","volume":"190","author":"Oskan","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13014-018-1089-8","article-title":"Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation","volume":"13","author":"Chen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0022","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaoncol.2023.7269","article-title":"Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial","volume":"10","author":"Palma","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.prro.2015.09.005","article-title":"It's never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival","volume":"6","author":"Roach","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0024","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.healun.2012.02.022","article-title":"Bronchial carcinoma after lung transplantation: a single-center experience","volume":"31","author":"Yserbyt","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cllc.2025.12.003_bib0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/JTO.0b013e31819afdd9","article-title":"Lung cancer and lung transplantation: a review","volume":"4","author":"Mathew","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.12.003_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2019.10.023","article-title":"Lung cancer surgical treatment after solid organ transplantation: a single center 30-year experience","volume":"139","author":"Drevet","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2025.12.003_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-017-0283-9","article-title":"The immune system in cancer metastasis: friend or foe?","volume":"5","author":"Janssen","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cllc.2025.12.003_bib0028","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2147\/OTT.S136259","article-title":"The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy","volume":"10","author":"Wang","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cllc.2025.12.003_bib0029","first-page":"E612","article-title":"Is staging mediastinoscopy necessary before stereotactic body radiotherapy for inoperable early stage lung cancer?","volume":"7","author":"Rwigema","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cllc.2025.12.003_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2018.05.075","article-title":"Effect of patient immune status on the efficacy of radiation therapy and recurrence-free survival among 805 patients with Merkel cell carcinoma","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.12.003_bib0031","first-page":"1229","article-title":"Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma","volume":"63","author":"Slone","year":"1979","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2025.12.003_bib0032","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.3390\/cancers14235915","article-title":"Impact of systemic autoimmune diseases on treatment outcomes and radiation toxicities in patients with stage I non-small cell lung cancer receiving stereotactic body radiation therapy: a matched case-control analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.cllc.2025.12.003_bib0033","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.cllc.2022.05.014","article-title":"Local control with single-fraction lung stereotactic body radiotherapy is not influenced by non-small cell lung cancer histologic subtype","volume":"23","author":"Videtic","year":"2022","journal-title":"Clin Lung Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:14:45Z","timestamp":1775042085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525730425003316"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.12.003","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung SBRT Outcomes for Inoperable Early-Stage Lung Cancer Are Impaired in Patients With Solid Organ Transplants","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}